FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41346811000001102: Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2504571000001111 Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2504581000001113 Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Is a Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Is a Brodilaten true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Salbutamol sulfate true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has AMP True Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start